JOONGKYEOM ANTIBODY THERAPY Trademark

Trademark Overview


On Tuesday, November 16, 2021, a trademark application was filed for JOONGKYEOM ANTIBODY THERAPY with the United States Patent and Trademark Office. The USPTO has given the JOONGKYEOM ANTIBODY THERAPY trademark a serial number of 79333375. The federal status of this trademark filing is REGISTERED as of Tuesday, April 4, 2023. This trademark is owned by JOONGKYEOM Co., Ltd.. The JOONGKYEOM ANTIBODY THERAPY trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Preparations of microorganisms for medical use; bacterial preparations for medical and veterinary use; diagnostic preparations for medical and veterinary use; cultures of microorganisms for medical and veterinary use; preparations of microorganisms for medical and veterinary use; bacteriological preparations for medical and veterinary use; biological preparations for medical purposes; diagnostic agents for medical use; medicinal diagnostic reagents; pharmaceutical preparations for diagnosis; preparations for diagnosing antibodies; pharmaceutical preparations for the treatment of antibodies

Wholesale store services featuring microorganisms for medical purposes; retail store services featuring microorganisms for medical purposes; wholesale store services featuring bacterial preparations for medical and veterinary use; retail store services featuring bacterial preparations for medical and veterinary use; wholesale store services featuring diagnostic preparations for medical and veterinary use; retail store services featuring diagnostic preparations for medical and veterinary use; business intermediary services relating to the matching of parties for purchase and sale of drugs for medical purposes; wholesale store services featuring drugs for medical purposes; retail store services featuring drugs for medical purposes; wholesale store services featuring medical preparations for diagnosing antibodies; retail store services featuring medical preparations for diagnosing antibodies; wholesale store services featuring medicinal diagnostic reagents; retail store services featuring...

Research and development of vaccines and medicines; advisory services relating to biotechnology; research relating to biotechnology; consulting services in the fields of biotechnology; biological research; medical research in the field of crude drugs; biochemical analysis; biochemistry research services; research on adult diseases; research relating to bacteriology; research services in the fields of cancerous diseases; development of pharmaceuticals; research relating to pharmaceuticals; advisory services relating to development of pharmaceuticals; pharmaceutical products evaluation; consultancy pertaining to pharmacology; research in the field of gene analysis; genetic research; research relating to medical products; medical research services
joongkyeom antibody therapy

General Information


Serial Number79333375
Word MarkJOONGKYEOM ANTIBODY THERAPY
Filing DateTuesday, November 16, 2021
Status700 - REGISTERED
Status DateTuesday, April 4, 2023
Registration Number7014770
Registration DateTuesday, April 4, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Description of MarkThe mark consists of the wording "JOONGKYEOM" stacked above the wording "ANTIBODY THERAPY", wherein an infinity symbol represents the letters "OO", all to the left of a stylized letter "X" and its shadow.
Goods and ServicesPreparations of microorganisms for medical use; bacterial preparations for medical and veterinary use; diagnostic preparations for medical and veterinary use; cultures of microorganisms for medical and veterinary use; preparations of microorganisms for medical and veterinary use; bacteriological preparations for medical and veterinary use; biological preparations for medical purposes; diagnostic agents for medical use; medicinal diagnostic reagents; pharmaceutical preparations for diagnosis; preparations for diagnosing antibodies; pharmaceutical preparations for the treatment of antibodies
Goods and ServicesWholesale store services featuring microorganisms for medical purposes; retail store services featuring microorganisms for medical purposes; wholesale store services featuring bacterial preparations for medical and veterinary use; retail store services featuring bacterial preparations for medical and veterinary use; wholesale store services featuring diagnostic preparations for medical and veterinary use; retail store services featuring diagnostic preparations for medical and veterinary use; business intermediary services relating to the matching of parties for purchase and sale of drugs for medical purposes; wholesale store services featuring drugs for medical purposes; retail store services featuring drugs for medical purposes; wholesale store services featuring medical preparations for diagnosing antibodies; retail store services featuring medical preparations for diagnosing antibodies; wholesale store services featuring medicinal diagnostic reagents; retail store services featuring medicinal diagnostic reagents; business intermediary services relating to the matching of parties for purchase and sale of medicinal diagnostic reagents; wholesale store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for diagnosis; business merchandising display services; wholesale store services featuring pharmaceutical preparations for the treatment of antibodies; retail store services featuring pharmaceutical preparations for the treatment of antibodies; sales agency services, namely, independent sale representatives for pharmaceutical preparations for the treatment of antibodies
NOT AVAILABLE"ANTIBODY THERAPY"
Goods and ServicesResearch and development of vaccines and medicines; advisory services relating to biotechnology; research relating to biotechnology; consulting services in the fields of biotechnology; biological research; medical research in the field of crude drugs; biochemical analysis; biochemistry research services; research on adult diseases; research relating to bacteriology; research services in the fields of cancerous diseases; development of pharmaceuticals; research relating to pharmaceuticals; advisory services relating to development of pharmaceuticals; pharmaceutical products evaluation; consultancy pertaining to pharmacology; research in the field of gene analysis; genetic research; research relating to medical products; medical research services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 15, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJOONGKYEOM Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameJOONGKYEOM Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameJOONGKYEOM Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Saturday, August 27, 2022NON-FINAL ACTION WRITTEN
Thursday, February 10, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, February 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 19, 2022APPLICATION FILING RECEIPT MAILED
Saturday, August 27, 2022ASSIGNED TO EXAMINER
Sunday, August 28, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 30, 2022NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Tuesday, August 30, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 31, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 21, 2022REFUSAL PROCESSED BY MPU
Saturday, October 22, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 14, 2022REFUSAL PROCESSED BY IB
Tuesday, December 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 4, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 4, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 25, 2023NOTIFICATION PROCESSED BY IB
Tuesday, April 4, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 4, 2023REGISTERED-PRINCIPAL REGISTER
Monday, July 24, 2023FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 24, 2023FINAL DISPOSITION PROCESSED
Tuesday, July 4, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, May 11, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, August 14, 2023FINAL DECISION TRANSACTION PROCESSED BY IB